Raymond James Upgrades CareDx to Outperform, Announces $12 Price Target
Portfolio Pulse from richadhand@benzinga.com
Raymond James analyst Andrew Cooper has upgraded CareDx (NASDAQ:CDNA) from Market Perform to Outperform and set a price target of $12.
August 15, 2023 | 9:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CareDx has been upgraded to Outperform by Raymond James, with a new price target of $12.
The upgrade from Market Perform to Outperform by Raymond James indicates a positive outlook for CareDx. The new price target of $12 also suggests potential upside for the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100